Hepatitis has been recognised as a hazard in renal dialysis units since 19651 and its association with hepatitis B surface antigen (HB5Ag) was recognised in 1968.2 3 However, there have been few systematic studies of the state of the liver in patients with renal failure who are chronic carriers of HBsAg4 5 6 We report here such a study, which draws attention to the frequent occurrence of chronic liver disease in such patients, to the association between the hepatitis B e antigen and chronic liver disease, and to the danger which e antigen positive patients pose to their home environment.
Methods

PATIENTS
During the period of the study, 1972-77, the prevalence of HBsAg in the 141 patients who received renal transplants was 16%, while 6% of the 181 patients on maintenance haemodialysis were HBsAg positive at some time. Of the total HBsAg positive group of 33 patients, 27 were eligible for study by virtue of being HB.Ag positive on monthly testing for six months or longer. Of this group 21 were *Address for reprint requests: Professor A. G. Wangel, Department of Medicine, The Queen Elizabeth, Woodville, South Australia,
5011.
Received for publication 23 August 1979 studied, 17 with functioning renal transplants receiving prednisolone and azathioprine and four on maintenance haemodialysis. In the remaining six, either biopsy was declined or the patient was dead and serum no longer available. The initial histological assessment was by liver biopsy followed by one or more subsequent biopsies over an average period of three years (12 patients) 
